Related Experiment Videos
[Practical control methods for the dose individualization of anticancer drugs]
Li-yan Wang1, Zhi-qiang Tang, Feng-yi Feng
1Department of Pharmacy, Cancer Hospital, Peking Union Medical College, Chinese Academy of Medical Science, Beijing 100021, P. R. China. wly211@hotmail.com
AI Zheng = Aizheng = Chinese Journal of Cancer
|January 11, 2003
Summary
Dose individualization is crucial for anticancer drugs due to toxicity and variable patient responses. This review explores strategies for optimizing chemotherapy dosage regimens in clinical practice and trials.
Area of Science:
- Pharmacology
- Oncology
- Clinical Pharmacy
Context:
- Anticancer drugs often exhibit a narrow therapeutic index, leading to significant inter-patient variability in pharmacokinetics.
- High toxicity and variable patient responses necessitate individualized dosing for chemotherapy agents.
- Optimizing dosage regimens is essential for improving treatment efficacy and reducing adverse events in cancer patients.
Purpose:
- To review strategies for optimizing anticancer drug dosage regimens.
- To assess the feasibility of these techniques in clinical practice and all stages of clinical trials.
- To provide insights into the application of dose individualization in chemotherapy.
Summary:
- This paper reviews various strategies for optimizing anticancer drug dosage regimens.
- It evaluates the practicality of these methods across different phases of clinical trials and patient care.
- The focus is on addressing the challenges posed by narrow therapeutic indices and inter-patient pharmacokinetic variability.
Impact:
- Facilitates informed decision-making for personalized cancer chemotherapy.
- Aims to enhance the safety and effectiveness of anticancer treatments through optimized dosing.
- Supports the integration of dose individualization strategies in routine clinical oncology practice and research.